Keen Eye Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 45
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $6.74M
Latest Deal Amount
  • Investors
  • 3

Keen Eye General Information

Description

Operator of healthcare technology intended to build machine learning technology for translational and clinical research. The company's technology permits doctors and biologists to reproduce and extend their visual expertise, notably by identifying signals with a high predictive value that are yet difficult to detect, enabling medical practitioners to save valuable time in day-to-day decision-making, whether it is to diagnose, screen disease or evaluate the effectiveness of a drug in a more precise and standardized way

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Outcome Management (Healthcare)
Other Industries
Media and Information Services (B2B)
Decision/Risk Analysis
Primary Office
  • Incubator Institute of Vision
  • 74 rue du Faubourg Saint Antoine
  • 75012 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Keen Eye Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 29-Apr-2019 $6.74M 00.000 000.00 Completed Generating Revenue
6. Early Stage VC 12-Dec-2016 00.00 00.000 00.000 Completed Generating Revenue
5. Angel (individual) 15-Jun-2016 000.00 00000 00.000 Completed Startup
4. Angel (individual) 01-Dec-2015 000.00 00000 00.000 Completed Startup
3. Angel (individual) 23-May-2015 000.00 00000 00.000 Completed Startup
2. Angel (individual) 26-Dec-2014 $142K $142K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Keen Eye’s complete valuation and funding history, request access »

Keen Eye Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P-2019 Shares 00,000 00.000000 0000.0 0000.0 00 0000.0 00.000
P-2016 Shares 00,000 00.000000 000.00 000.00 00 000.00 00.000
O Shares 0,000 00.000000 000.00 000.00 000.00 0.000
O Shares 0,000 00.000000 000.00 000.00 000.00 0.000
O Shares 000 00.000000 000.00 000.00 000.00 0.000
O Shares 3,800 $0.011230 $33.97 $33.97 $33.97 1.71%
O Shares 100,000 $0.011230
To view Keen Eye’s complete cap table history, request access »

Keen Eye Executive Team (5)

Name Title Board Seat Contact Info
Sylvain Berlemont Ph.D Founder & Chief Executive Officer
Mathias Monnerville Chief Technology Officer
Philippe Tramoy Member of the Strategic Advisory Board
To view Keen Eye’s complete executive team members history, request access »

Keen Eye Board Members (3)

Name Representing Role Since
Gaudenz Danuser Ph.D Self Chairman 000 0000
Karine Lignel Crédit Mutuel Equity Board Member 000 0000
To view Keen Eye’s complete board members history, request access »

Keen Eye Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Keen Eye Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Crédit Mutuel Equity Growth/Expansion Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0
Incubateur Insitut de La Vision Accelerator/Incubator Minority 000 0000 000000 0
To view Keen Eye’s complete investors history, request access »